3G42

Crystal Structure of TACE with Tryptophan Sulfonamide Derivative Inhibitor

Summary for 3G42

Entry DOI	10.2210/pdb3g42/pdb
Related	1BKC 1ZXC 2A8H 2I47
Descriptor	ADAM 17, N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan, ZINC ION, ... (4 entities in total)
Functional Keywords	tace/adam-17, tace-inhibitor complex, zn-endopeptidase, alternative splicing, cleavage on pair of basic residues, glycoprotein, hydrolase, membrane, metal-binding, metalloprotease, notch signaling pathway, phosphoprotein, polymorphism, protease, sh3-binding, transmembrane, zinc, zymogen
Biological source	Homo sapiens (human)
Cellular location	Membrane; Single-pass type I membrane protein: P78536
Total number of polymer chains	4
Total formula weight	132321.05
Authors	Xu, W.,Park, K.,Gopalsamy, A.,Aplasca, A.,Zhang, Y.H.,Levin, J.I. (deposition date: 2009-02-03, release date: 2009-05-19, Last modification date: 2023-09-06)
Primary citation	Park, K.,Gopalsamy, A.,Aplasca, A.,Ellingboe, J.W.,Xu, W.,Zhang, Y.,Levin, J.I. Synthesis and activity of tryptophan sulfonamide derivatives as novel non-hydroxamate TNF-alpha converting enzyme (TACE) inhibitors. Bioorg.Med.Chem., 17:3857-3865, 2009 Cited by PubMed: 19410464 DOI: 10.1016/j.bmc.2009.04.033 PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (2.1 Å)

Structure validation